BRENTUXIMAB VEDOTIN
Clinical trials for BRENTUXIMAB VEDOTIN explained in plain language.
Never miss a new study
Get alerted when new BRENTUXIMAB VEDOTIN trials appear
Sign up with your email to follow new studies for BRENTUXIMAB VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lymphoma: drug combo targets tough cancer
Disease control Not yet recruitingThis study tests whether adding brentuximab vedotin to standard chemotherapy (R-CHP) works better for people newly diagnosed with a rare, aggressive lymphoma linked to the Epstein-Barr virus. About 25 adults will receive the combination and be followed for 2 years to see if the c…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug aims to stop skin lymphoma from returning after transplant
Disease control Not yet recruitingThis phase 3 trial tests whether the drug brentuximab vedotin can prevent relapse in people with advanced cutaneous T-cell lymphoma (CTCL) who have recently had a stem cell transplant. About 84 adults with CD30-positive CTCL will receive either the drug or a placebo every three w…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC